Parallax Volatility Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.41M Buy
90,400
+87,900
+3,516% +$8.42M 0.02% 484
2025
Q4
$240K Buy
2,500
+800
+47% +$77.7K ﹤0.01% 1354
2025
Q3
$162K Sell
1,700
-35,800
-95% -$3.29M ﹤0.01% 1387
2025
Q2
$3.27M Sell
37,500
-35,000
-48% -$2.97M 0.01% 740
2025
Q1
$6.51M Sell
72,500
-41,800
-37% -$3.74M 0.02% 548
2024
Q4
$9.13M Sell
114,300
-79,200
-41% -$6.86M 0.02% 602
2024
Q3
$17.4M Sell
193,500
-64,400
-25% -$5.42M 0.03% 367
2024
Q2
$20.3M Buy
257,900
+236,900
+1,128% +$19.4M 0.04% 299
2024
Q1
$1.83M Sell
21,000
-272,300
-93% -$23.2M ﹤0.01% 1057
2023
Q4
$24.2M Buy
293,300
+72,300
+33% +$5.51M 0.05% 340
2023
Q3
$17.3M Sell
221,000
-53,000
-19% -$4.44M 0.04% 370
2023
Q2
$24.1M Buy
274,000
+183,500
+203% +$15.8M 0.05% 300
2023
Q1
$7.3M Sell
90,500
-775,800
-90% -$63.2M 0.01% 695
2022
Q4
$67.3M Buy
866,300
+517,800
+149% +$42M 0.1% 219
2022
Q3
$28.1M Sell
348,500
-379,700
-52% -$34.1M 0.04% 429
2022
Q2
$65.4M Sell
728,200
-161,800
-18% -$16.4M 0.06% 214
2022
Q1
$98.7M Buy
890,000
+271,600
+44% +$28.7M 0.05% 137
2021
Q4
$64M Buy
618,400
+187,200
+43% +$21.7M 0.07% 191
2021
Q3
$54.1M Buy
431,200
+9,100
+2% +$1.18M 0.05% 236
2021
Q2
$52.4M Buy
+422,100
New +$53M 0.07% 184
2021
Q1
Sell
-218,500
Closed -$25.6M 1878
2020
Q4
$25.6M Sell
218,500
-532,100
-71% -$58.6M 0.03% 462
2020
Q3
$78M Buy
750,600
+278,300
+59% +$27.9M 0.06% 282
2020
Q2
$43.3M Sell
472,300
-203,600
-30% -$19.5M 0.05% 299
2020
Q1
$60.9M Buy
675,900
+599,600
+786% +$63.8M 0.08% 178
2019
Q4
$8.66M Sell
76,300
-112,300
-60% -$12.3M 0.01% 701
2019
Q3
$20.5M Sell
188,600
-20,600
-10% -$2.15M 0.02% 395
2019
Q2
$20.4M Sell
209,200
-241,900
-54% -$22.1M 0.02% 352
2019
Q1
$41.1M Sell
451,100
-977,100
-68% -$87.5M 0.05% 193
2018
Q4
$130M Buy
1,428,200
+492,300
+53% +$46M 0.17% 88
2018
Q3
$92.1M Sell
935,900
-524,500
-36% -$48.5M 0.11% 76
2018
Q2
$125M Buy
1,460,400
+417,500
+40% +$34.9M 0.18% 55
2018
Q1
$83.7M Buy
1,042,900
+788,300
+310% +$65M 0.11% 92
2017
Q4
$20.6M Hold
254,600
0.03% 254
2017
Q3
$19.8M Buy
254,600
+84,600
+50% +$7.02M 0.03% 269
2017
Q2
$15.1M Buy
170,000
+4,400
+3% +$371K 0.03% 313
2017
Q1
$13.3M Sell
165,600
-34,400
-17% -$2.69M 0.03% 320
2016
Q4
$14.2M Hold
200,000
0.03% 352
2016
Q3
$17.3M Buy
200,000
+180,600
+931% +$15.7M 0.03% 304
2016
Q2
$1.68M Buy
+19,400
New +$1.57M ﹤0.01% 987
2015
Q4
Sell
-187,500
Closed -$12.6M 3503
2015
Q3
$12.6M Buy
187,500
+134,300
+252% +$9.89M 0.03% 363
2015
Q2
$3.94M Buy
53,200
+50,000
+1,563% +$3.82M 0.01% 801
2015
Q1
$250K Hold
3,200
﹤0.01% 1942
2014
Q4
$231K Sell
3,200
-60,200
-95% -$4.18M ﹤0.01% 2722
2014
Q3
$3.93M Buy
63,400
+45,300
+250% +$2.88M 0.01% 811
2014
Q2
$1.15M Sell
18,100
-592,100
-97% -$36M ﹤0.01% 988
2014
Q1
$37.6M Buy
610,200
+510,600
+513% +$29.7M 0.22% 94
2013
Q4
$5.71M Sell
99,600
-75,300
-43% -$4.27M 0.03% 403
2013
Q3
$9.31M Buy
174,900
+46,000
+36% +$2.48M 0.05% 268
2013
Q2
$6.63M Buy
+128,900
New +$6.37M 0.03% 358

Other funds holding MDT

Parallax Volatility Advisers's MDT Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its Medtronic (MDT) stake by 90% in Q1 2026, selling an estimated $1.77M and leaving 1,956 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Parallax Volatility Advisers first reported a position in MDT in Q3 2014 and has held it in 21 quarters since. The position peaked at $33.3M in Q2 2019. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Parallax Volatility Advisers held 1,956 shares of Medtronic worth $160K as of Q1 2026.
  • Parallax Volatility Advisers sold 18,431 Medtronic shares in Q1 2026, an estimated $1.77M.
  • Medtronic made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1199 holding.
  • Parallax Volatility Advisers first reported a position in Medtronic in Q3 2014 and has held it in 21 quarters since.
  • Parallax Volatility Advisers's Medtronic position peaked at $33.3M in Q2 2019.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.